annual D&A:
$1.38M+$1.37M(+10390.15%)Summary
- As of today (September 14, 2025), MLTX annual depreciation & amortization is $1.38 million, with the most recent change of +$1.37 million (+10390.15%) on December 31, 2024.
- During the last 3 years, MLTX annual D&A has risen by +$1.38 million (+27594.00%).
- MLTX annual D&A is now at all-time high.
Performance
MLTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$742.00K+$364.00K(+96.30%)Summary
- As of today (September 14, 2025), MLTX quarterly depreciation & amortization is $742.00 thousand, with the most recent change of +$364.00 thousand (+96.30%) on June 30, 2025.
- Over the past year, MLTX quarterly D&A has increased by +$713.90 thousand (+2540.57%).
- MLTX quarterly D&A is now -42.98% below its all-time high of $1.30 million, reached on December 31, 2024.
Performance
MLTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$2.45M+$713.90K(+41.03%)Summary
- As of today (September 14, 2025), MLTX TTM depreciation & amortization is $2.45 million, with the most recent change of +$713.90 thousand (+41.03%) on June 30, 2025.
- Over the past year, MLTX TTM D&A has increased by +$2.40 million (+4167.48%).
- MLTX TTM D&A is now at all-time high.
Performance
MLTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
MLTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +2540.6% | +4167.5% |
| 3 y3 years | +10000.0% | +10000.0% | +10000.0% |
| 5 y5 years | - | - | - |
MLTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -43.0% | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -43.0% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -43.0% | >+9999.0% | at high | >+9999.0% |
MLTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $742.00K(+96.3%) | $2.45M(+41.0%) |
| Mar 2025 | - | $378.00K(-71.0%) | $1.74M(+25.7%) |
| Dec 2024 | $1.38M(>+9900.0%) | $1.30M(+3904.0%) | $1.38M(+1497.1%) |
| Sep 2024 | - | $32.50K(+15.7%) | $86.70K(+50.8%) |
| Jun 2024 | - | $28.10K(+23.2%) | $57.50K(+75.8%) |
| Mar 2024 | - | $22.80K(+590.9%) | $32.70K(+147.7%) |
| Dec 2023 | $13.20K | $3300.00(0.0%) | $13.20K(0.0%) |
| Sep 2023 | - | $3300.00(0.0%) | $13.20K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $3300.00(0.0%) | $13.20K(0.0%) |
| Mar 2023 | - | $3300.00(0.0%) | $13.20K(+6.5%) |
| Dec 2022 | $12.40K(+148.0%) | $3300.00(0.0%) | $12.40K(+6.9%) |
| Sep 2022 | - | $3300.00(0.0%) | $11.60K(+9.4%) |
| Jun 2022 | - | $3300.00(+32.0%) | $10.60K(+45.2%) |
| Mar 2022 | - | $2500.00(0.0%) | $7300.00(+52.1%) |
| Dec 2021 | $5000.00 | $2500.00(+8.7%) | $4800.00(+108.7%) |
| Sep 2021 | - | $2300.00 | $2300.00 |
FAQ
- What is MoonLake Immunotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual D&A year-on-year change?
- What is MoonLake Immunotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly D&A year-on-year change?
- What is MoonLake Immunotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM D&A year-on-year change?
What is MoonLake Immunotherapeutics annual depreciation & amortization?
The current annual D&A of MLTX is $1.38M
What is the all time high annual D&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual depreciation & amortization is $1.38M
What is MoonLake Immunotherapeutics annual D&A year-on-year change?
Over the past year, MLTX annual depreciation & amortization has changed by +$1.37M (+10390.15%)
What is MoonLake Immunotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of MLTX is $742.00K
What is the all time high quarterly D&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly depreciation & amortization is $1.30M
What is MoonLake Immunotherapeutics quarterly D&A year-on-year change?
Over the past year, MLTX quarterly depreciation & amortization has changed by +$713.90K (+2540.57%)
What is MoonLake Immunotherapeutics TTM depreciation & amortization?
The current TTM D&A of MLTX is $2.45M
What is the all time high TTM D&A for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM depreciation & amortization is $2.45M
What is MoonLake Immunotherapeutics TTM D&A year-on-year change?
Over the past year, MLTX TTM depreciation & amortization has changed by +$2.40M (+4167.48%)